←
Health Care Network554 posts
Health Care Network avatar✓

Health Care Network ✓

@watchhcn

Healthcare's group chat, on the record. Live every Thursday

◷ Joined June 2026▧ 263 Photos and videos
Health Care Network avatar
Health Care Network@watchhcn·Nov 12

Today on HCN • What do the Dems need to do next? Kody Kinsley, former North Carolina HHS Secretary, on post-midterm health care affordability • New FDA GLP-1 warning on NAION eye stroke: how scared should we be? • Are Medicaid stocks a buy right now? Grant Hesser on the CVS split and the payers • Novartis' pelacarsen fails to improve cardiovascular outcomes in 8,300 participants • Bookmarks: the best things we found on the internet this week x.com/i/broadcasts/2gqkYWLXZ…

Health Care Network avatar
Health Care Network@watchhcn·Nov 17

AMA CEO Dr. John Whyte @drjohnwhyte has raised his concerns about Medicare's new AI framework with @DrOz In his reading, the AI handles care until something goes wrong, and then it hands off to a doctor, who takes the blame. We got the details LIVE at #HLTHUSA #hlth202

0:58
Health Care Network avatar
Health Care Network@watchhcn·Nov 13

Few people have seen the health system the way @KodyKinsley has as former North Carolina HHS Secretary. He sat down with us to talk coverage, costs, and what Washington gets wrong.

0:32
Health Care Network avatar
Health Care Network@watchhcn·Nov 11

Tomorrow, we sit down with @KodyKinsley, former North Carolina HHS Secretary, on medical debt and what new governors should do first. We also talk to @GrantHesser of Hesser & Company on the CVS split and why he's bullish on Medicaid going into 2027. This and more on HCN!

Post attachmentPost attachment
Health Care Network avatar
Health Care Network@watchhcn·Nov 11

Is a vial of BPC-157 in your fridge the new MAGA hat in your closet? Peptides have picked up a political reputation fast, and if you mention them at dinner, people lump you in with the RFK crowd. We’re not convinced it’s that simple. Blue peptide folks, weigh in!

1:02
Health Care Network avatar
Health Care Network@watchhcn·Nov 11

The FDA's pooled look at 126 trials found 15 probable cases of this eye condition among 134,253 patients. 10 were on a GLP-1 and 5 were on placebo. That's rare, but it was enough to put a warning on every drug in the class. The tricky part is that the FDA's list of NAION risk factors includes diabetes, high blood pressure, and sleep apnea, which are the same conditions a lot of people take these drugs for. That overlap makes the drug's own share of the risk hard to pin down.

Health Care Network avatar
Health Care Network@watchhcn·Nov 10

Congrats to @julesyoo on Oura's $625 million deal for Counsel Health. She chatted with us on Ep. 9 of HCN, and her write-up here on why Counsel and Oura fit together is worth the read.